Skip to content

menu

Data Protection Report logo
HomeAboutContact
Search
Close
Compliance and risk managementRegulatory responseData breachCybersecurity
View topics Archives
Subscribe

Data Protection Report

Data protection legal insight at the speed of technology

final guidance

Subscribe to final guidance via RSS
Home

FDA issues final guidance on postmarket medical device cybersecurity

Photo of Anna Rudawski (US)
By Anna Rudawski (US) on January 5, 2017

On December 28, 2016, the U.S. Food and Drug Administration (FDA) released final guidance on the management of cybersecurity vulnerabilities for marketed and distributed medical devices.  The guidance establishes a risk-based approach for the reporting of medical device cybersecurity vulnerabilities to the FDA.

Data Protection Report

Facebook Twitter RSS LinkedIn YouTube
Published by
Norton Rose Fulbright LLP logo
DisclaimerPrivacy policy

About

More than a news source, the Data Protection Report provides thought leadership on emerging privacy, data protection and cybersecurity issues, and helps its readers proactively address risks and anticipate next steps in this crucial emerging field.

Read more

Topics

Archives

Copyright © 2025, Norton Rose Fulbright LLP. All rights reserved.